Evaluation of growth hormone administration in patients with chronic heart failure secondary to coronary artery disease

American Journal of Cardiology

Volumn 84, Issue 4, 1999, Pages 430-433

  Spallarossa, Paolo ^a   Rossettin, Piefranco ^a   Minuto, Francesco ^b   Caruso, Davide ^a   Cordera, Renzo ^b   Battistini, Micaela ^b   Barreca, Antonina ^b   Masperone, Maria Augusta ^a   Brunelli, Claudio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HUMAN GROWTH HORMONE; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE WALL; HUMAN; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; WELLBEING;

AGED; BODY MASS INDEX; CORONARY DISEASE; DRUG EVALUATION; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE TEST; FOLLOW-UP STUDIES; GROWTH HORMONE; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; STROKE VOLUME; TREATMENT OUTCOME;

EID: 0033566836     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00328-8     Document Type: Article

References (22)

1. Cuneo R.C., Salomon F., Watts G.F., Hesp R., Sonksen P.H. Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism. 42:1993;1519-1523.
2. Salomon F., Cuneo R.C., Hesp R., Inst M., Sonksen P.H. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 321:1989;1797-1803.
3. Rosen T., Bengtsson B.-A. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 336:1990;285-288.
4. Markussis V., Beshyah S.A., Fisher C., Sharp P., Nicolaides A.N., Johnston D.G. Detection of premature atherosclerosis by high-resolution ultrasonography in symtom-free hypopituitary adults. Lancet. 340:1992;1188-1192.
5. Spallarossa P., Brunelli C., Minuto F., Caruso D., Battistini M., Caponnetto S., Cordera R. Insulin-like growth factor-I and angiographically documented coronary artery disease. Am J Cardiol. 77:1996;200-202.
6. Janssen J.A.M.J.L., Stolk R.P., Pols H.A.P., Grobbee D.E., Lamberts S.W.J. Serum total IGF-I, free IGF-I, and IGFBP-1 levels in an elderly population. Relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol. 1998;277-282.
7. Cittadini A., Strömer H., Katz S.E., Clark R., Moses A.C., Morgan J.P., Douglas P.S. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and vitro evaluation. Circulation. 93:1996;800-829.
8. Cittadini A., Grossman J.D., Napoli R., Katz S.E., Strömer H., Smith R.J., Clark R., Morgan J.P., Douglas P.S. Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction. J Am Coll Cardiol. 29:1997;1109-1116.
9. Yang R., Bunting S., Gillett N., Clark R., Hongkui J. Growth hormone improves cardiac performance in experimental heart failure. Circulation. 92:1995;262-267.
10. Fazio S., Sabatini D., Capaldo B., Vigorito C., Giordano A., Guida R., Pardo F., Biondi B., Saccà L. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med. 334:1996;809-814.
11. Osterziel K.J., Strohm O., Schuler J., Friedrich M., Hänlein D., Willenbrock R., Anker S.D., Poole-Wilson P.A., Ranke M.B., Dietz R. Randomised double blind placebo controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet. 351:1998;1233-1237.
12. Sahn D.J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography results of a survey of echocardiographic measurements . Circulation. 58:1978;1072-1083.
13. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Guttgsell H., Reichek N., Sahn D., Schnittger I., Silverman N.H., Tajik A.J. Recommendations for quantitation of the left ventricle by two dimensional echocardiography. J Am Soc Echocardiogr. 2:1989;358-367.
14. Russell-Jones D.L., Cuneo R.C., Salomon F., Hesp R., Sonksen P.H., Weissberger A.J. Changes in body composition in adult growth hormone deficient patients withdrawn from long-term treatment comparison of total body potassim and bioelectrical measurements . (abstr) J Endocrinol. 132:(suppl):1992;232.
15. Isgaard J., Bergh C.-H., Caidahl K., Lomsky M., Hjalmarson Å., Bengtsson B-Å. A placebo controlled study of growth hormone in patients with congestive heart failure. Eur Heart J. 19:1998;1704-1711.
16. Frustaci A., Gentiloni N., Russo M.A. Growth hormone in treatment of dilated cardiomyopathy. N Engl J Med. 335:1996;672-673.
17. Volterrani M., Desenzani P., Lorusso R., D'Aloia A., Manelli F., Giustina A. Haemodynamic effects of intravenous growth hormone in congestive heart failure. Lancet. 349:1997;1067-1068.
18. Khardori R., Taraben A., Taylor G.J., Falcone M. Acute effects of growth hormone infusion in patients with advanced congestive heart failure. [letter] Lancet. 349:1997;1842.
19. Fowelin J., Attvall S., Lager I., Bengtsson B-Å. Effect of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism. 42:1993;1443-1447.
20. Hasdai D., Rizza R.A., Holmes D.R. Jr, Richardson D.M., Cohen P., Lerman A. Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro. Hypertension. 32:1998;228-234.
21. Böger R.H., Skamira C., Bode-Böger S.M., Brabant G., von zur Mühlen A., Frölich J.C. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double blind placebo controlled study. J Clin Invest. 98:1996;2706-2713.
22. Cooke J.P., Tsao P.S. Is NO an endogenous antianterogenic molecule? Arterioscler Thromb. 14:1994;653-655.